David Lyle - Surgalign Holdings Chief Officer

SRGADelisted Stock  USD 0.04  0  12.54%   

Insider

David Lyle is Chief Officer of Surgalign Holdings
Age 59
Phone224 303 4651
Webhttps://www.surgalign.com

Surgalign Holdings Management Efficiency

The company has return on total asset (ROA) of (0.3494) % which means that it has lost $0.3494 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (14.9702) %, meaning that it created substantial loss on money invested by shareholders. Surgalign Holdings' management efficiency ratios could be used to measure how well Surgalign Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
Surgalign Holdings currently holds 10.19 M in liabilities with Debt to Equity (D/E) ratio of 0.54, which is about average as compared to similar companies. Surgalign Holdings has a current ratio of 2.28, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Surgalign Holdings' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Michelle MissalParagon 28
N/A
John EsqAinos Inc
57
Mojirade JamesAvanos Medical
57
Jeff WelchBioventus
N/A
Jason EdieParagon 28
N/A
Christopher YamamotoBioventus
N/A
Laura PiersonAccelerate Diagnostics
N/A
Matt JarboeParagon 28
N/A
David CrawfordAvanos Medical
N/A
Heather BrennanEstablishment Labs Holdings
N/A
John MeduriAccelerate Diagnostics
N/A
Mark HughesHyperfine
61
Danielle WatsonHeart Test Laboratories
42
Paul VerrastroCVRx Inc
61
Jeffrey BettingerEstablishment Labs Holdings
N/A
Scott WhiteHyperfine
50
Ryan SabiaTivic Health Systems
37
Rajbir DenhoyEstablishment Labs Holdings
53
Ehab EsmailOrthofix Medical
52
Meghan ScanlonParagon 28
48
Khan MDHyperfine
50
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. Surgalign Hldg operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 231 people. Surgalign Holdings (SRGA) is traded on NASDAQ Exchange in USA and employs 217 people.

Management Performance

Surgalign Holdings Leadership Team

Elected by the shareholders, the Surgalign Holdings' board of directors comprises two types of representatives: Surgalign Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Surgalign. The board's role is to monitor Surgalign Holdings' management team and ensure that shareholders' interests are well served. Surgalign Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Surgalign Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher Thunander, VP Officer
William Durall, Chief Officer
Enrico Sangiorgio, Ex International
David Lyle, Chief Officer
Suzanne Zoumaras, Chief Officer
Olivier Visa, Pres OEM
Paolo Amoruso, Gen Officer
Terry Rich, CEO Pres
Bob Watkins, Chief Officer
John Varela, Ex Operations

Surgalign Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Surgalign Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Consideration for investing in Surgalign Stock

If you are still planning to invest in Surgalign Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surgalign Holdings' history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Fundamental Analysis
View fundamental data based on most recent published financial statements
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
FinTech Suite
Use AI to screen and filter profitable investment opportunities